A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Clinical trial NCT07519395 · RECRUITING

Trial details

NCT number: NCT07519395
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2026-04-08
Primary completion: 2027-03-09
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.